Here, we aimed to explore the mutation spectrum of SMAD3 and SMAD4 by screening the highly conserved MH2 domain in the germline DNA in familial and non-familial breast cancer cases as well as age, gender and ethnicity matched healthy population controls. This evidence concerns the gene SMAD3 and breast carcinoma.